BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 38677759)

  • 21. The number of positive nodes and the ratio of positive to excised nodes are significant predictors of survival in women with micrometastatic node-positive breast cancer.
    Truong PT; Vinh-Hung V; Cserni G; Woodward WA; Tai P; Vlastos G;
    Eur J Cancer; 2008 Aug; 44(12):1670-7. PubMed ID: 18595686
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lymph node counts and ratio in axillary dissections following neoadjuvant chemotherapy for breast cancer: a better alternative to traditional pN staging.
    Chen S; Liu Y; Huang L; Chen CM; Wu J; Shao ZM
    Ann Surg Oncol; 2014 Jan; 21(1):42-50. PubMed ID: 24013900
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Axillary lymph node ratio and total number of removed lymph nodes: predictors of survival in stage I and II breast cancer.
    van der Wal BC; Butzelaar RM; van der Meij S; Boermeester MA
    Eur J Surg Oncol; 2002 Aug; 28(5):481-9. PubMed ID: 12217299
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The lymph node ratio as an independent prognostic factor for node-positive triple-negative breast cancer.
    He M; Zhang JX; Jiang YZ; Chen YL; Yang HY; Tang LC; Shao ZM; Di GH
    Oncotarget; 2017 Jul; 8(27):44870-44880. PubMed ID: 28496004
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association between Lymph Node Ratio and Disease Specific Survival in Breast Cancer Patients with One or Two Positive Lymph Nodes Stratified by Different Local Treatment Modalities.
    Hong R; Dai Z; Zhu W; Xu B
    PLoS One; 2015; 10(10):e0138908. PubMed ID: 26513258
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The prognostic value of lymph node ratio in survival of non-metastatic breast carcinoma patients.
    Singh D; Mandal A
    Breast Cancer Res Treat; 2020 Dec; 184(3):839-848. PubMed ID: 32852709
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The lymph node ratio as an independent prognostic factor for non-metastatic node-positive breast cancer recurrence and mortality.
    Solak M; Turkoz FP; Keskin O; Aksoy S; Babacan T; Sarici F; Kertmen N; Sever AR; Altundag K
    J BUON; 2015; 20(3):737-45. PubMed ID: 26214625
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Number of Positive Lymph Nodes Is Superior to LNR and LODDS for Predicting the Prognosis of Pancreatic Neuroendocrine Neoplasms.
    Gao B; Zhou D; Qian X; Jiang Y; Liu Z; Zhang W; Wang W
    Front Endocrinol (Lausanne); 2021; 12():613755. PubMed ID: 33746899
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Breast cancer preoperative
    Vinh-Hung V; Everaert H; Gorobets O; Van Parijs H; Verfaillie G; Vanhoeij M; Storme G; Fontaine C; Lamote J; Perrin J; Farid K; Nguyen NP; Verschraegen C; De Ridder M
    Breast Cancer; 2021 Jul; 28(4):956-968. PubMed ID: 33689151
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Log odds of positive lymph nodes is a superior prognostic indicator in stage III rectal cancer patients: A retrospective analysis of 17,632 patients in the SEER database.
    Huang B; Chen C; Ni M; Mo S; Cai G; Cai S
    Int J Surg; 2016 Aug; 32():24-30. PubMed ID: 27321382
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic value of lymph node ratio in stage IIIC epithelial ovarian cancer with node-positive in a SEER population-based study.
    Zhou J; He ZY; Li FY; Sun JY; Lin HX; Wu SG; Chen QH
    Oncotarget; 2016 Feb; 7(7):7952-9. PubMed ID: 26788911
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metastatic lymph node ratio successfully predicts prognosis in western gastric cancer patients.
    Kutlu OC; Watchell M; Dissanaike S
    Surg Oncol; 2015 Jun; 24(2):84-8. PubMed ID: 25912951
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metastatic axillary lymph node ratio (LNR) is prognostically superior to pN staging in patients with breast cancer--results for 804 Chinese patients from a single institution.
    Xiao XS; Tang HL; Xie XH; Li LS; Kong YN; Wu MQ; Yang L; Gao J; Wei WD; Xie X
    Asian Pac J Cancer Prev; 2013; 14(9):5219-23. PubMed ID: 24175804
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The prognostic value of different lymph node classification systems in stage III colorectal cancer patients.
    Gulmez S; Senger AS; Uzun O; Olmez T; Ofluoglu C; Oz A; Omeroglu S; Polat E; Duman M
    Ann Ital Chir; 2020; 91():504-511. PubMed ID: 32390652
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Metastatic lymph node ratio and outcome of surgical patients with stage III colorectal cancer].
    Liang J; Wei Y; Zhao C; Hong C
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 Nov; 32(11):1663-6. PubMed ID: 23174600
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metastatic lymph node ratio is a more precise predictor of prognosis than number of lymph node metastases in stage III colon cancer.
    Chin CC; Wang JY; Yeh CY; Kuo YH; Huang WS; Yeh CH
    Int J Colorectal Dis; 2009 Nov; 24(11):1297-302. PubMed ID: 19479270
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lymph node ratio should be considered for incorporation into staging for breast cancer.
    Chagpar AB; Camp RL; Rimm DL
    Ann Surg Oncol; 2011 Oct; 18(11):3143-8. PubMed ID: 21847696
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lymph Node Ratio in Sentinel Lymph Node Biopsy Era: Are We Losing Prognostic Information?
    Quintyne KI; Woulfe B; Coffey JC; Merrigan A; Gupta RK
    Clin Breast Cancer; 2017 Apr; 17(2):117-126. PubMed ID: 27592541
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic value of number of removed lymph nodes, number of involved lymph nodes, and lymph node ratio in 7502 breast cancer patients enrolled onto trials of the Austrian Breast and Colorectal Cancer Study Group (ABCSG).
    Tausch C; Taucher S; Dubsky P; Seifert M; Reitsamer R; Kwasny W; Jakesz R; Fitzal F; Filipcic L; Fridrik M; Greil R; Gnant M
    Ann Surg Oncol; 2012 Jun; 19(6):1808-17. PubMed ID: 22207051
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lymph node ratio: role in the staging of node-positive colon cancer.
    Wang J; Hassett JM; Dayton MT; Kulaylat MN
    Ann Surg Oncol; 2008 Jun; 15(6):1600-8. PubMed ID: 18327530
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.